There was no significantly different expression of BTLA on CD4+ T-cells between healthy controls and inactive SLE patients (90.4% ± 3.9% vs. 89.8% ± 3.6%, p = 0.69). This evidence concerns the gene BTLA and systemic lupus erythematosus.